Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status.
Autor: | Aspite, Silvia1 (AUTHOR), Schepis, Filippo2 (AUTHOR), Roccarina, Davide1 (AUTHOR), Gitto, Stefano1 (AUTHOR), Citone, Michele3 (AUTHOR), Di Bonaventura, Chiara1 (AUTHOR), Bianchini, Marcello2 (AUTHOR), Arena, Umberto1 (AUTHOR), Vannucchi, Alessandro M.1,4,5 (AUTHOR), Guglielmelli, Paola1,4,5 (AUTHOR), Campani, Francesca6 (AUTHOR), Fanelli, Fabrizio3 (AUTHOR), Marra, Fabio1,5 (AUTHOR), Vizzutti, Francesco1 (AUTHOR) francesco.vizzutti@unifi.it |
---|---|
Zdroj: | Liver International. Feb2022, Vol. 42 Issue 2, p419-424. 6p. 1 Color Photograph, 1 Chart, 1 Graph. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |